Skip to main content
Clinical Trials/NCT01570920
NCT01570920
Completed
Not Applicable

Effects of Regular Brisk Walking in Chronic Stroke Patients

Cliniques universitaires Saint-Luc- Université Catholique de Louvain1 site in 1 country34 target enrollmentSeptember 2009
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Enrollment
34
Locations
1
Primary Endpoint
ACTIVLIM-Stroke (Activity limitations measures)
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

Chronic stroke patients (>6 months) fulfilling including criteria were trained during 3 months. The physical training program was based on walking.

Detailed Description

Participants had been evaluated 4 times during a long follow-up period of 7 months. Activity limitations were assessed at baseline (enrollment time point), 1 month, 4 months and 7 months later.

Registry
clinicaltrials.gov
Start Date
September 2009
End Date
March 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Stroke onset \> or = 6 months
  • Able to walk without human assistance (may use walking aid)
  • Sign informed consent form
  • Approval from physician for participation in study
  • Live in Belgium or in Benin

Exclusion Criteria

  • cardiac history of active unstable angina, recent (less than 3 months) myocardial infarction, or congestive heart failure
  • orthopedic, circulatory, or chronic pain conditions restricting exercise;
  • dementia;
  • severe receptive or global aphasia with inability to follow 2-step commands;
  • co-morbid non-stroke neurological disorder that impairs mobility (e.g. MS or Parkinson's);

Outcomes

Primary Outcomes

ACTIVLIM-Stroke (Activity limitations measures)

Time Frame: 7 months

mainly self-reported outcomes measures

Secondary Outcomes

  • Stroke Impairment(7 months)
  • Walking ability(7 months)

Study Sites (1)

Loading locations...

Similar Trials